ARNI OTC
Arno Therapeutics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: +0.0%
3Y: -95.2%
5Y: -92.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$8K
+0.0% ▲
Operating Income
-$13M
+37.6% ▲
Net Income
-$12M
-248.5% ▼
EPS (Diluted)
$-0.57
-283.9% ▼
EBITDA
-$13M
+37.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $8K |
| Gross Profit | $0 | $0 | $0 | $0 | -$8K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $6M | $9M | $13M | $15M | $9M |
| SG&A Expenses | $2M | $2M | $3M | $7M | $5M |
| Operating Expenses | $8M | $11M | $17M | $21M | $13M |
| Operating Income | -$8M | -$11M | -$17M | -$21M | -$13M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $6M | $19M | $143 | $28K |
| Income Before Tax | -$8M | -$14M | -$40M | $8M | -$12M |
| Tax Expense | $262K | $0 | $0 | $143 | $28K |
| Net Income | -$8M | -$21M | -$58M | $8M | -$12M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.90 | $-4.57 | $-7.75 | $0.31 | $-0.57 |
| EBITDA | -$7M | -$14M | -$17M | -$21M | -$13M |
| Shares Outstanding | 4M | 5M | 8M | 25M | 20M |